Jiangsu Aoyang Health Industry Co.ltd. (002172.SZ)
CNY 3.62
(2.26%)
CNY 3.62
(2.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 54.3 Million | -33.8 Million | -33.46 Million | 125.32 Million | -627.62 Million | -179.61 Million |
| Net Income | 50.26 Million | -15.75 Million | -1.06 Billion | -471.22 Million | -569.21 Million | -46.29 Million |
| Depreciation & Amortization | 72.42 Million | 76.23 Million | 221.2 Million | 305.86 Million | 232.08 Million | 240.4 Million |
| Deferred income taxes | -554.85 Thousand | -2.61 Million | -895.71 Thousand | -1.77 Million | 1.78 Million | 14.19 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -93.96 Million | -168.79 Million | -125.01 Million | 132.39 Million | -537.51 Million | -496.91 Million |
| Other non-cash items | 45.93 Million | 74.52 Million | 937.54 Million | 158.29 Million | 247.02 Million | 123.17 Million |
| Investing Cash Flow | -43.83 Million | 896.52 Million | 274.53 Million | -58.31 Million | -448.69 Million | -1.05 Billion |
| Investments in PPE | -63.59 Million | -193.16 Million | -221.11 Million | -177.22 Million | -253.22 Million | -1.11 Billion |
| Acquisitions | 24.41 Million | 25.59 Million | 495.65 Million | 188.59 Million | 5.97 Million | -6.94 Million |
| Investment purchases | -4.75 Million | -1.82 Million | - | -1.45 Billion | -672.5 Thousand | -2.75 Million |
| Sales/Maturities of investments | - | 34.71 Million | - | 24.31 Million | 19.36 Million | 59.05 Million |
| Other Investing Activities | 19.75 Million | 1.03 Billion | -0.14 | 1.36 Billion | -220.14 Million | 4.11 Million |
| Financing Cash Flow | -11.42 Million | -640.32 Million | -572.19 Million | 14.36 Million | 1.09 Billion | 1.06 Billion |
| Debt repayment | -17.24 Million | -1.86 Billion | -3.05 Billion | -2.58 Billion | -2.44 Billion | -2.7 Billion |
| Dividends payments | -34.56 Million | -48.22 Million | -110.02 Million | -119.24 Million | -181.89 Million | -94.73 Million |
| Common Stock Repurchased | - | - | - | - | - | -185.43 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 8.14 Million | 1.27 Billion | 2.59 Billion | 2.71 Billion | 3.72 Billion | 3.86 Billion |
| Accounts receivables | 118.05 Million | 224.05 Million | 982.66 Million | -1.34 Billion | -982.4 Million | 61.28 Million |
| Accounts payables | -203.7 Million | -396.22 Million | -1.2 Billion | 1.34 Billion | 215.67 Million | -238.02 Million |
| Inventory | -7.76 Million | 5.98 Million | 93.75 Million | 138.71 Million | 227.44 Million | -334.36 Million |
| Other working capital | -204.26 Million | -2.61 Million | -895.71 Thousand | -1.77 Million | 1.78 Million | -162.54 Million |
| Cash at beginning of period | 354.91 Million | 132.45 Million | 463.6 Million | 382.21 Million | 368.25 Million | 548.04 Million |
| Cash at end of period | 353.97 Million | 354.91 Million | 132.45 Million | 463.6 Million | 382.21 Million | 368.25 Million |
| Capital Expenditure | -63.59 Million | -193.16 Million | -221.11 Million | -177.22 Million | -253.22 Million | -1.11 Billion |
| Effect of forex changes on cash | 16.21 Thousand | 66.08 Thousand | -28.22 Thousand | 9840.17 | -5.51 Million | -6.32 Million |
| Net cash flow / Change in cash | -944.27 Thousand | 222.45 Million | -331.15 Million | 81.38 Million | 13.96 Million | -179.78 Million |
| Free Cash Flow | -9.29 Million | -226.97 Million | -254.58 Million | -51.89 Million | -880.84 Million | -1.29 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.35 Million | 6.58 Million | 30.73 Million | 50.26 Million | 10.01 Million | 4.2 Million |
| Depreciation & Amortization | - | 15.44 Million | 15.44 Million | 72.42 Million | 72.42 Million | -32.95 Million |
| Deferred income taxes | - | - | - | -554.85 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 98.54 Million | - | -93.96 Million | 110.29 Million | -148.99 Million |
| Other non-cash items | 22.82 Million | -32.53 Million | -242.75 Million | 45.93 Million | 46.59 Million | -146.72 Million |
| Investing Cash Flow | -17.07 Million | -43.88 Million | -15.78 Million | -43.83 Million | -5.74 Million | -1.73 Million |
| Investments in PPE | -17.08 Million | -36.3 Million | -13.17 Million | -63.59 Million | -16.98 Million | -2.42 Million |
| Acquisitions | 2400.00 | 2.61 Million | -2.61 Million | 24.41 Million | 18.2 Million | 938.82 Thousand |
| Investment purchases | - | -10.2 Million | - | -4.75 Million | - | -3.75 Million |
| Sales/Maturities of investments | - | - | - | - | -6.07 Million | 3.5 Million |
| Other Investing Activities | 2400.00 | -10.18 Million | 397.00 | 19.75 Million | 11.24 Million | 0.77 |
| Financing Cash Flow | -85.91 Million | -97.09 Million | 292.57 Million | -11.42 Million | -180.57 Million | 276.26 Million |
| Debt repayment | -67.5 Million | -114.47 Million | -230.57 Million | -17.24 Million | -164.54 Million | -339.59 Million |
| Dividends payments | -9.5 Million | -7.48 Million | -10.54 Million | -34.56 Million | -4.24 Million | -10.54 Million |
| Common Stock Repurchased | - | - | - | - | -1.5 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -8.9 Million | 25.76 Million | 72.54 Million | 8.14 Million | -11.78 Million | 626.39 Million |
| Accounts receivables | - | 92.68 Million | - | 118.05 Million | 118.05 Million | -149.3 Million |
| Accounts payables | - | - | - | -203.7 Million | - | - |
| Inventory | - | 5.85 Million | - | -7.76 Million | -7.76 Million | 312.77 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 236.37 Million | 418.74 Million | 353.97 Million | 354.91 Million | 300.97 Million | 350.91 Million |
| Cash at end of period | 157.54 Million | 236.37 Million | 418.74 Million | 353.97 Million | 353.97 Million | 300.97 Million |
| Capital Expenditure | -17.08 Million | -36.3 Million | -13.17 Million | -63.59 Million | -16.98 Million | -2.42 Million |
| Effect of forex changes on cash | -16.39 Thousand | 4366.76 | 1689.19 | 16.21 Thousand | -13.33 Thousand | -6316.53 |
| Net cash flow / Change in cash | -78.83 Million | -182.36 Million | 64.77 Million | -944.27 Thousand | 52.99 Million | -49.94 Million |
| Free Cash Flow | 7.09 Million | -77.7 Million | -225.19 Million | -9.29 Million | 222.34 Million | -326.88 Million |
VEGGD
FHYD
OSX
LWSA3
603336
600618